Drug Trial Radar · NCT05319353
A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT)
Last checked: Nov 19, 2026Latest source record: May 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
80
Planned (sponsor's estimate)
Start
Nov 13, 2023
Primary completion
Jan 18, 2027
Study completion Jan 18, 2027
Sponsor
- Lead sponsor
- TakedaTakeda (TAK)
- Sponsor type
- Industry
- Collaborators
- Takeda Development Center Americas, Inc.
- First posted
- Apr 8, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main aim of this study is to find out the safety, tolerability and pharmacokinetics (PK) of maribavir for the treatment of CMV infection in children and teenagers after HSCT or SOT and to identify the optimal dose of maribavir using a 200 milligrams (mg) tablet formulation or powder for oral suspension. The participants will be treated with maribavir for 8 weeks. Participants need to visit their doctor during 12-week follow-up period.
Conditions
- Cytomegalovirus (CMV)
Interventions
MaribavirDrug
Participants will receive maribavir.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Maximum Observed Plasma Concentration (Cmax) of MaribavirTime frame: Pre-dose; 0.5, 1.5, 3, 4, 6, and 8 hours post-dose on Day 7 (Week 1)
- Time to Maximum Observed Concentration (Tmax) of MaribavirTime frame: Pre-dose; 0.5, 1.5, 3, 4, 6, and 8 hours post-dose on Day 7 (Week 1)
- Minimum Plasma Concentration (Cmin) of MaribavirTime frame: Pre-dose; (0.5, 1.5, 3, 4, 6, and 8 hours post-dose) on Day 7 (Week 1); Pre-dose on Day 28 (Week 4); Pre-dose; (2 to 4 hours post-dose) on Day 56 (Week 8)
- Area Under the Plasma Concentration-Time Curve Over the 1 Dosing Interval of 12 Hours at Steady State (AUC0-tau) of MaribavirTime frame: Pre-dose; 0.5, 1.5, 3, 4, 6, and 8 hours post-dose on Day 7 (Week 1)
- Half-Life (t1/2) of MaribavirTime frame: Pre-dose; 0.5, 1.5, 3, 4, 6, and 8 hours post-dose on Day 7 (Week 1)
- Terminal Elimination Rate Constant (lambdaz) of MaribavirTime frame: Pre-dose; 0.5, 1.5, 3, 4, 6, and 8 hours post-dose on Day 7 (Week 1)
- Apparent Volume of Distribution (Vz/F) of MaribavirTime frame: Pre-dose; 0.5, 1.5, 3, 4, 6, and 8 hours post-dose on Day 7 (Week 1)
- Apparent Oral Clearance (CL/F) of MaribavirTime frame: Pre-dose; 0.5, 1.5, 3, 4, 6, and 8 hours post-dose on Day 7 (Week 1)
- Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs)Time frame: From start of study drug administration up to follow-up (Week 20)
Locations
53 sites in 11 countries. Site status is shown where the registry gives one.
Nemours Children's Health - Wilmington - PIN
Wilmington, Delaware · Recruiting
Johns Hopkins All Children's Hospital - Main - PIN
St. Petersburg, Florida · Recruiting
Ann and Robert H Lurie Childrens Hospital of Chicago - PIN
Chicago, Illinois · Recruiting
University of Nebraska Medical Center -985400 Nebraska Medical Center
Omaha, Nebraska · Recruiting
Cincinnati Children's Hospital Medical Center - PIN
Cincinnati, Ohio · Recruiting
Cook Children's Health Care System
Fort Worth, Texas · Recruiting
University of Texas MD Anderson Cancer Center - 1515 Holcombe Blvd
Houston, Texas · Recruiting
Texas Children's Hospital - Wallace Tower - PIN
Houston, Texas · Recruiting
Minderoo Children's Comprehensive Cancer Centre
Randwick, New South Wales, Australia · Recruiting
Queensland Children's Hospital
Woollangabba, Queensland, Australia · Recruiting
Royal Children's Hospital Melbourne - PIN
Parkville, Victoria, Australia · Recruiting
Perth Children's Hospital
Nedlands, Western Australia, Australia · Recruiting
Hôpital Universitaire des Enfants Reine Fabiola (HUDERF)
Brussels, Brussels Capital, Belgium · Recruiting
Cliniques Universitaires Saint-Luc
Woluwe-Saint-Lambert, Brussels Capital, Belgium · Recruiting
UZ Gent
Ghent, Oost-Vlaanderen, Belgium · Recruiting
Hospital Do Rim E Hipertensão
São Paulo, Brazil · Recruiting
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Porto Alegre, Rio Grande do Sul, Brazil · Recruiting
Irmandade Da Santa Casa de Misericordia de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil · Recruiting
Hospital de Clinicas de Porto Alegre (HCPA) - PPDS
Porto Alegre, Rio Grande do Sul, Brazil · Recruiting
Capital Center For Children's Healthy, Capital Medical University
Beijing, Beijing Municipality, China · Recruiting
Beijing Children's Hospital, Capital Medical University - PIN
Beijing, Beijing Municipality, China · Recruiting
The First Affiliated Hospital, Sun Yat-sen University - Main
Guangzhou, Guangdong, China · Recruiting
Shenzhen Children's Hospital
Shenzhen, Guangdong, China · Recruiting
Shanghai Children's Medical Center - Zhangjiang Campus
Shanghai, Shanghai Municipality, China · Recruiting
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences - PPDS
Tianjin, Tianjin Municipality, China · Recruiting
Hopital Necker
Paris, France · Recruiting
CHU de Rennes - Hôpital Pontchaillou
Rennes, Ille-et-Vilaine, France · Recruiting
CHU de Grenoble Alpes - Hôpital Michallon
La Tronche, Isère, France · Recruiting
CHRU Nantes
Nantes, Loire-Atlantique, France · Recruiting
Universitätsklinikum Hamburg Eppendorf
Hamburg, Germany · Recruiting
Medizinische Hochschule Hannover
Hanover, Germany · Recruiting
Universitätsklinikum Würzburg
Würzburg, Bavaria, Germany · Recruiting
Universitätsklinikum Münster
Münster, North Rhine-Westphalia, Germany · Recruiting
Universitatsklinikum Jena - Am Klinikum 1-Erlanger Allee 101
Jena, Thuringia, Germany · Recruiting
Rambam Health Care Campus - PPDS
Haifa, Israel · Recruiting
Hadassah Medical Center- Ein Kerem - PPDS
Petah Tikva, Israel · Recruiting
The Chaim Sheba Medical Center - PPDS
Ramat Gan, Tel Aviv, Israel · Recruiting
Tel Aviv Sourasky Medical Center Ichilov - PPDS
Tel Aviv, Tel Aviv, Israel · Recruiting
Hyogo Prefectural Kobe Children's Hospital
Chiba, Japan · Recruiting
Osaka Women's and Children's Hospital
Izumi-Shi, Ôsaka, Japan · Recruiting
Showing 40 of 53 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.